Cancer pain emergencies: a protocol for management

Area of Science:

• Oncology
• Pain Management
• Pharmacology

Background:

• Cancer patients frequently experience chronic pain.
• Cancer pain emergencies require distinct, rapid analgesic strategies beyond standard chronic pain management.
• Existing protocols for severe cancer pain crises are not well-defined.

Purpose of the Study:

• To evaluate the efficacy and safety of rapid opioid dose escalation for managing cancer pain emergencies.
• To establish a clear protocol for addressing severe, acute cancer pain episodes.

Main Methods:

• A protocol involving intravenous opioid boluses with rapid dose titration was applied to ten cancer pain emergencies in nine patients.
• Opioid doses were doubled every 30 minutes until effective analgesia was achieved.
• Patient outcomes, including pain relief duration and toxicity, were monitored.

Main Results:

• All patients achieved relief from excruciating pain, with a mean time to analgesia of 89 minutes (range: 4-215 minutes).
• No significant opioid toxicity was observed in any patient during the management of their pain emergency.
• The rapid dose escalation protocol proved effective in achieving pain control.

Conclusions:

• Repeated intravenous opioid boluses, with dose doubling every 30 minutes, represent an effective and safe management strategy for cancer pain emergencies.
• This protocol offers a viable solution for the rapid control of severe cancer pain.
• Further validation studies are recommended to confirm these findings.